These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 19959985

  • 41. Impact of alternative approaches to accelerated measles control: experience in the African region, 1996-2002.
    Otten MW, Okwo-Bele JM, Kezaala R, Biellik R, Eggers R, Nshimirimana D.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S36-43. PubMed ID: 12721884
    [Abstract] [Full Text] [Related]

  • 42. Progress in measles and rubella elimination in Iran.
    Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F.
    Pediatr Infect Dis J; 2007 Dec 15; 26(12):1137-41. PubMed ID: 18043452
    [Abstract] [Full Text] [Related]

  • 43. Measles control in Sub-Saharan Africa: South Africa as a case study.
    Verguet S, Jassat W, Hedberg C, Tollman S, Jamison DT, Hofman KJ.
    Vaccine; 2012 Feb 21; 30(9):1594-600. PubMed ID: 22230581
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Global routine vaccination coverage, 2011.
    Centers for Disease Control and Prevention.
    MMWR Morb Mortal Wkly Rep; 2012 Nov 02; 61(43):883-5. PubMed ID: 23114256
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Progress Toward Regional Measles Elimination - Worldwide, 2000-2016.
    Dabbagh A, Patel MK, Dumolard L, Gacic-Dobo M, Mulders MN, Okwo-Bele JM, Kretsinger K, Papania MJ, Rota PA, Goodson JL.
    MMWR Morb Mortal Wkly Rep; 2017 Oct 27; 66(42):1148-1153. PubMed ID: 29073125
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Achieving measles control: lessons from the 2002-06 measles control strategy for Uganda.
    Mbabazi WB, Nanyunja M, Makumbi I, Braka F, Baliraine FN, Kisakye A, Bwogi J, Mugyenyi P, Kabwongera E, Lewis RF.
    Health Policy Plan; 2009 Jul 27; 24(4):261-9. PubMed ID: 19282484
    [Abstract] [Full Text] [Related]

  • 57. Global routine vaccination coverage, 2010.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2011 Nov 11; 60(44):1520-2. PubMed ID: 22071590
    [Abstract] [Full Text] [Related]

  • 58. Supplementary immunization activities to achieve measles elimination: experience of the European Region.
    Khetsuriani N, Deshevoi S, Goel A, Spika J, Martin R, Emiroglu N.
    J Infect Dis; 2011 Jul 11; 204 Suppl 1():S343-52. PubMed ID: 21666183
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Current impact of measles in Latin America.
    Borgoño JM.
    Rev Infect Dis; 1983 Jul 11; 5(3):417-21. PubMed ID: 6878992
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.